REUTERS PRESS DIGEST - Wall Street Journal - April 12 [FYMPLPW]
April 12 (Reuters) - The following were the top stories in
The Wall Street Journal on Wednesday. Reuters has not verified
these stories and does not vouch for their accuracy.
* Plaintiffs' attorneys are setting their sights on another
Merck & Co. Inc. <MRK.N> drug, Fosamax, that they say is linked
to a rare jaw disease.
* Iran is enriching uranium, in direct defiance of a United
Nations Security Council demand that it suspend sensitive
nuclear activity. The announcement seems intended to show
Tehran won't yield to international pressure to desist.
* Jeffrey Skilling's attorney worked to portray him as a
dedicated, even selfless, executive who didn't take part in any
criminal activities in the former Enron Corp. president's
second day of testimony.
* Nasdaq Stock Market Inc. <NDAQ.O> snapped up nearly 15
percent of London Stock Exchange Plc <LSE.L> shares, less than
two weeks after abandoning an offer to buy the London exchange.
That sounds about right a minority holding but a holding nonetheless... -dsd
* Russia and the U.S. are closing in on a trade deal by
midyear that could clear the way for Moscow to join the World
Trade Organization.
* A Merrill Lynch & Co. <MER.N> analyst was charged with
providing insider information allegedly used in making at least
$6.4 million on stock trades.
* Summer gasoline prices will be at least 25 cents a gallon
more than last year's, the government said, driven by Gulf
damage and a shift to ethanol.
(
AI
